Sandeep Chavan, Gupta Vidya, Deshmukh Vineeta, Sardeshmukh Sadanand
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, 412 207, India; Atharva Nature Healthcare Pvt Ltd, Wagholi, Pune, 412 207, India.
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, 412 207, India.
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100954. doi: 10.1016/j.jaim.2024.100954. Epub 2024 Oct 19.
Ayurveda is a holistic science emphasizing healing and maintaining harmony and balance in the body. Medicines from natural resources and in pre-defined dosage forms are integral parts of successful Ayurvedic treatment in various diseases including complex ailments, such as cancer. Ayurvedic medicines are cocktails of several active phyto-compounds and/or natural resources and no isolated/purified molecules are used in the treatment. However, various unique methods employed using natural media, such as water, lipids, buttermilk, and lemon juice, just to name a few, lead to the elimination of unwanted constituents/impurities and enhance the bioavailability and efficacy of the drug. Such plausible alterations, selection, and/or retention of signature phytocompounds in the raw materials, during the process, and in the final drug need to be studied for precise product identification and analysis. Critical standardization of the manufacturing procedures is, therefore, mandatory for quality fidelity, assurance, and optimum efficacy. Moreover, the simultaneous multi-level and/or multi-targeted actions of Ayurvedic medicines against various dysfunctions due to their complex nature makes it extremely challenging to understand the mechanistic aspects during pre-clinical and clinical studies. The present article focuses on probable challenges and ideal roadmaps for standardization and characterization of such herbal as well as metallic-mineral Ayurvedic medicines being used for various simple and complex diseases like cancer and their treatments. It is emphasized that Ayurvedic manufacturing procedures should be followed meticulously and the finished product be characterized thoroughly using advanced pharmaceutical and analytical techniques. It is also accentuated that detailed monographs or dossiers including shelf-life studies need to be officially published for knowledge dissemination and worldwide acceptance. Finally, safety and efficacy studies as per modern pharmacology ought to be conducted in suitable animal models for the judicious use of these medicines. Mainstream or adjuvant treatment of dreadful diseases such as cancer with Ayurvedic medicines will only be fruitful through rational experimentation and ethical reporting.
阿育吠陀是一门整体科学,强调治愈并维持身体的和谐与平衡。来自自然资源且呈预定义剂型的药物是包括癌症等复杂疾病在内的各种疾病成功进行阿育吠陀治疗的重要组成部分。阿育吠陀药物是几种活性植物化合物和/或自然资源的混合物,治疗中不使用分离/纯化的分子。然而,使用天然介质(如水、脂质、酪乳和柠檬汁等仅举几例)所采用的各种独特方法可导致去除不需要的成分/杂质,并提高药物的生物利用度和疗效。在原材料、加工过程以及最终药物中,对标志性植物化合物进行这种合理的改变、选择和/或保留,需要进行研究以实现精确的产品鉴定和分析。因此,制造程序的关键标准化对于质量保真、保证和最佳疗效而言是必不可少的。此外,由于其复杂的性质,阿育吠陀药物针对各种功能障碍的同时多水平和/或多靶点作用使得在临床前和临床研究期间理解其作用机制极具挑战性。本文重点关注用于治疗癌症等各种简单和复杂疾病的此类草药以及金属矿物阿育吠陀药物标准化和特性描述的可能挑战及理想路线图。强调应严格遵循阿育吠陀制造程序,并使用先进的制药和分析技术对成品进行全面表征。还着重指出,应正式出版包括保质期研究在内的详细专著或档案以进行知识传播和全球认可。最后,应在合适的动物模型中按照现代药理学进行安全性和疗效研究,以便明智地使用这些药物。只有通过合理的实验和符合伦理的报告,用阿育吠陀药物对癌症等可怕疾病进行主流或辅助治疗才会有成效。